Biden administration unveils first 10 drugs subject to Medicare price negotiations

[IronLionZion]

44. Epipens have some unique issues complicating things

there needs to be more generic options available and for schools to not require only the brand name. Their monopoly power needs to be diminished through competition. There are alternatives but many state and local laws require the brand name.

Since schools and children are a major consumer block, Medicare's negotiating power is very limited.